naturallyoccur
attenu
strain
newcastl
diseas
viru
ndv
develop
vaccin
vector
use
poultri
human
howev
ndv
strain
beaudett
c
bc
may
retain
much
virul
poultri
safe
use
highli
attenu
strain
may
suboptim
immunogen
therefor
modifi
bc
strain
chang
multibas
cleavag
site
sequenc
f
protein
dibas
sequenc
avirul
strain
lasota
addit
bc
f
hn
protein
modifi
sever
way
enhanc
viru
replic
modifi
bcderiv
vector
lasota
strain
engin
express
hemagglutin
ha
protein
highli
pathogen
influenza
viru
hpaiv
gener
modifi
bcbase
vector
express
ha
replic
better
lasotaha
express
higher
level
ha
protein
pathogen
test
indic
modifi
virus
highli
attenu
chicken
base
vitro
character
two
modifi
bc
vector
chosen
evalu
chicken
vaccin
vector
hpaiv
immun
chicken
rndv
vector
vaccin
follow
challeng
hpaiv
demonstr
high
level
protect
clinic
diseas
mortal
howev
chicken
immun
modifi
bcha
residu
f
protein
replac
correspond
sequenc
ndv
ako
strain
confer
complet
protect
challeng
viru
shed
find
suggest
modifi
rndv
use
safe
vaccin
vector
enhanc
replic
express
protect
efficaci
avian
speci
potenti
human
newcastl
diseas
viru
vector
vaccin
hemagglutinin
highli
virul
avian
influenza
viru
newcastl
diseas
viru
ndv
member
famili
paramyxovirida
nonseg
negativesens
rna
genom
contain
six
gene
ndv
isol
categor
three
pathotyp
base
virul
chicken
lentogen
avirul
mesogen
moder
virul
velogen
virul
lentogen
mesogen
strain
ndv
wide
use
live
attenu
vaccin
control
newcastl
diseas
poultri
addit
ndv
modifi
revers
genet
express
one
protect
antigen
repres
heterolog
pathogen
one
applic
modifi
ndv
express
protect
antigen
anoth
poultri
pathogen
creat
bival
vaccin
exampl
ndv
engin
express
hemagglutinin
ha
gene
highli
pathogen
avian
influenza
hpaiv
viru
protein
infecti
bursal
diseas
viru
ibdv
creat
bival
vaccin
ndv
hpaiv
ibdv
respect
anoth
applic
use
develop
ndv
strain
potenti
vaccin
vector
human
emerg
reemerg
pathogen
hpaiv
sever
acut
respiratori
syndrom
coronaviru
sarscov
although
lentogen
mesogen
strain
potenti
veterinari
human
vaccin
vector
nonhuman
primat
mesogen
strain
beaudett
c
bc
replic
higher
titer
induc
substanti
higher
antibodi
respons
compar
lentogen
strain
lasota
thu
appear
effect
howev
ndv
strain
polybas
cleavag
site
f
protein
intracerebr
pathogen
index
icpi
classifi
select
agent
mesogen
strain
includ
strain
bc
fall
categori
even
though
pathogen
potenti
chicken
limit
select
agent
classif
render
impract
vaccin
develop
use
therefor
endeavor
develop
ndv
vaccin
vector
would
effect
lentogen
strain
yet
would
avirul
phenotyp
evalu
new
ndv
vector
use
express
ha
protein
hpaiv
hpaiv
econom
import
diseas
poultri
worldwid
particular
hpaiv
subtyp
infect
result
cull
death
million
poultri
countri
furthermor
strain
found
caus
diseas
human
therefor
vaccin
poultri
human
hpaiv
could
play
import
role
reduc
viru
shed
rais
threshold
infect
transmiss
howev
develop
vaccin
hpaiv
hamper
due
poor
immunogen
viru
develop
manufactur
hpaiv
vaccin
base
inactiv
viru
costli
due
requir
enhanc
biosafeti
level
contain
therefor
vaccin
platform
avoid
shortcom
need
live
ndv
vector
repres
altern
approach
remark
modifi
version
bc
strain
express
ha
protein
hpaiv
found
avirul
icpi
test
evalu
select
construct
replic
immunogen
protect
efficaci
chicken
result
show
two
modifi
vector
superior
commonli
use
rlasota
vector
modifi
previous
describ
full
length
cdna
antigenom
strain
bc
chang
naturallyoccur
f
protein
cleavag
site
motif
strain
lasota
creat
rbclascfc
backbon
modifi
replac
variou
region
f
gene
velogen
ndv
strain
ako
complet
hn
protein
gene
strain
lasota
fig
particularli
replac
region
f
gene
encod
amino
acid
rbcla
fc
correspond
segment
ako
strain
strain
ako
chosen
strain
replic
high
titer
vitro
vivo
chose
segment
preliminari
work
show
modif
enhanc
viru
replic
syncytium
format
vitro
data
shown
consequ
also
enhanc
vivo
replic
immunogen
vaccin
vector
infecti
virus
gener
use
revers
genet
establish
laboratori
vivo
replic
immunogen
modifi
rndv
evalu
chicken
eight
bird
per
group
bird
inocul
viru
ha
unitsbird
intranas
rout
three
bird
group
sacrif
day
postinfect
dpi
tissu
sampl
lung
trachea
spleen
brain
collect
viru
titrat
serum
sampl
collect
day
evalu
seroconvers
hemagglutin
inhibit
hi
assay
ha
gene
orf
hpaiv
strain
modifi
pcr
insert
p
gene
antigenom
cdna
rlasota
modifi
rndv
addit
origin
polybas
cleavag
site
ha
gene
pqrerrrkkg
replac
lowpathogen
influenza
viru
strain
achickenmexico
pqretg
infecti
virus
gener
revers
genet
express
ha
protein
rndv
incorpor
vector
particl
evalu
western
blot
surfac
express
ha
protein
evalu
virusinfect
cell
moi
immunofluoresc
microscopi
flow
cytometri
multicycl
growth
kinet
rndv
evalu
cell
presenc
chicken
egg
allanto
fluid
pathogen
rndvha
vector
evalu
mean
embryo
death
time
mdt
embryon
chicken
egg
icpi
assay
chick
group
n
per
group
spf
chicken
infect
oculonas
rout
eid
per
bird
rlasotaha
rndvako
f
rndvla
hnha
addit
group
bird
n
left
uninfect
follow
immun
prechalleng
serum
sampl
collect
weekli
bird
eight
bird
group
challeng
eld
hpaiv
strain
avietnam
week
postimmun
wpi
remain
eight
bird
challeng
way
wpi
immun
control
group
bird
challeng
wpi
monitor
shed
challeng
viru
oral
cloacal
swab
collect
day
postchalleng
inocul
spf
embryon
chicken
egg
confirm
ha
assay
use
chicken
erythrocyt
three
chicken
group
sacrif
day
postchalleng
evalu
challeng
viru
replic
differ
organ
brain
trachea
lung
spleen
experi
involv
virul
ndv
hpaiv
perform
usda
approv
enhanc
biosafeti
facil
seri
modifi
version
rbc
fig
recov
passag
seven
time
chick
sequenc
f
gene
virus
confirm
rtpcr
sequenc
analysi
correct
vivo
replic
immunogen
rndv
evalu
chicken
fig
c
bird
sacrif
dpi
rbc
replic
detect
trachea
lung
spleen
brain
wherea
replic
rlasota
detect
trachea
fig
two
modifi
virus
rbcla
fc
rndvako
f
remain
restrict
trachea
two
modifi
virus
rndvako
f
rndvako
f
replic
trachea
lung
fig
modifi
vector
replic
effici
rlasota
p
rndvako
f
rndvako
f
two
virus
replic
trachea
lung
induc
higher
level
ndvspecif
serum
antibodi
rlasota
modifi
virus
wpi
modifi
virus
induc
higher
level
serum
antibodi
rlasota
wpi
p
fig
engin
rlasota
three
modifi
rbc
vector
describ
well
rbc
hn
gene
replac
lasota
fig
express
ha
protein
hpaiv
strain
fig
recov
virus
passag
seven
time
embryon
chicken
egg
virus
replic
effici
egg
hauml
sequenc
f
ha
gene
found
correct
multicycl
growth
kinet
rndv
bear
hpaiv
ha
gene
show
modifi
rbc
virus
replic
effici
rlasota
rlasotaha
first
hpi
fig
specif
rbcderiv
virus
reach
log
tcid
ml
hpi
wherea
rlasota
rlasotaha
titer
log
tcid
ml
respect
hpi
express
ha
rndv
evalu
cell
presenc
allanto
fluid
despit
presenc
ad
proteas
condit
ha
detect
uncleav
precursor
ha
molecular
weight
kda
express
ha
protein
could
detect
h
postinfect
hpi
case
three
modifi
rndv
ako
f
ako
f
la
hn
fig
subsequ
express
ha
detect
rndv
hpi
hpi
modifi
rndv
contain
ako
f
la
hn
express
higher
level
ha
virus
incorpor
ha
vector
particl
analyz
western
blot
fig
ha
protein
detect
form
ha
well
larger
subunit
cleav
form
ha
molecular
weight
kda
incorpor
ha
vector
particl
observ
variou
extent
rlasota
parent
vector
modifi
rndv
vector
particular
contain
f
la
hn
fig
twofold
increas
incorpor
ha
protein
vector
particl
rndvla
hnha
compar
rlasotaha
next
evalu
surfac
express
ha
protein
cell
immunofluoresc
microscopi
fig
similar
result
western
blot
modifi
rndv
contain
ako
f
la
hn
express
higher
level
ha
protein
surfac
cell
furthermor
quantit
confirm
flow
cytometri
fig
result
identifi
rndv
vector
contain
ako
f
la
hn
enhanc
ha
express
incorpor
ha
protein
viru
particl
pathogen
rndv
express
ha
protein
evalu
mdt
icpi
assay
tabl
avirul
natur
rlasota
affect
either
assay
express
hpaiv
ha
protein
mdt
valu
modifi
rndv
express
ha
protein
h
icpi
valu
indic
modifi
rndv
vector
avirul
chicken
chick
infect
rndv
appar
clinic
sign
period
icpi
test
confirm
attenu
modifi
rndv
twoweekold
chicken
group
infect
intranas
rlasotaha
rndvako
f
rndvla
hnha
left
uninfect
n
determin
abil
modifi
virus
induc
rndvspecif
hpaivspecif
immun
respons
serum
sampl
collect
wpi
test
hpaiv
fig
highli
virul
ndv
strain
gb
texa
fig
use
hpaivspecif
ndvspecif
hi
assay
studi
immun
respons
gb
texa
evalu
potenti
use
ndv
vector
dual
vaccin
hpaivspecif
assay
hi
titer
increas
time
reach
highest
titer
wpi
two
modifi
rndv
vector
induc
higher
haspecif
antibodi
titer
rlasota
vector
p
ndvspecif
assay
increas
antibodi
titer
time
somewhat
less
differ
virus
somewhat
less
highest
ndvspecif
antibodi
titer
observ
modifi
rndv
vector
although
less
evid
wpi
evalu
protect
efficaci
rndv
immun
chicken
divid
two
group
challeng
two
differ
time
point
wpi
wpi
group
eight
bird
three
unimmun
control
challeng
eld
homolog
hpaiv
via
oculonas
rout
unimmun
chicken
challeng
hpaiv
viru
result
clinic
sign
day
postchalleng
dpc
mortal
dpc
contrast
immun
chicken
complet
protect
clinic
diseas
mortal
follow
hpaiv
challeng
determin
shed
replic
hpaiv
challeng
viru
collect
oral
cloacal
swab
dpc
tissu
sampl
brain
lung
trachea
spleen
dpc
immun
chicken
group
challeng
wpi
challeng
hpaiv
shed
detect
dpc
oral
cloacal
swab
chicken
immun
rlasotaha
modifi
rndvla
hnha
wherea
shed
detect
dpc
chicken
immun
modifi
rndvako
f
viru
tabl
shed
observ
swab
taken
dpc
viru
recov
tissu
specimen
collect
dpc
data
shown
group
challeng
wpi
singl
bird
rlasotaha
group
detect
shed
oral
swab
dpc
tabl
shed
detect
bird
dpi
viru
detect
tissu
sampl
collect
dpc
data
shown
data
indic
immun
group
chicken
effici
protect
dose
hpaiv
rapidli
fatal
unimmun
bird
modifi
rndv
vector
appear
protect
rlasota
ndv
develop
bival
vaccin
vector
protect
chicken
ndv
poultri
pathogen
addit
ndv
shown
promis
result
potenti
vaccin
vector
human
use
ndv
attract
vaccin
vector
human
highli
attenu
nonhuman
primat
common
human
pathogen
antigen
distinct
common
human
pathogen
thu
unaffect
preexist
immun
given
topic
respiratori
tract
induc
mucos
system
immun
although
lentogen
mesogen
ndv
strain
use
vaccin
vector
mesogen
strain
easili
grown
vitro
immunogen
vivo
howev
mesogen
strain
might
caus
diseas
poultri
strain
classifi
select
agent
preclud
develop
vaccin
vector
therefor
chang
polybas
f
cleavag
site
mesogen
strain
bc
dibas
f
cleavag
site
strain
lasota
would
elimin
one
criteria
classifi
bc
select
agent
also
confirm
recov
viru
stabli
maintain
modifi
f
protein
cleavag
site
seven
passag
chicken
sinc
revers
f
protein
cleavag
site
sequenc
requir
mutat
nucleotid
exist
distanc
possibl
revers
virul
genet
stabil
cleavag
site
sequenc
viru
attenu
need
care
evalu
insert
differ
foreign
gene
vaccin
vector
prior
use
field
addit
swap
region
f
gene
strain
ako
swap
hn
gene
rlasota
done
fusogen
activ
ndv
affect
viru
replic
vitro
vivo
modul
enhanc
potenti
rndv
use
vaccin
vector
result
modifi
rbc
virus
found
restrict
replic
rbc
parent
immunogen
rlasota
strain
chicken
use
vector
express
ha
glycoprotein
hpaiv
hpaiv
virus
major
concern
poultri
industri
public
health
need
develop
effect
vaccin
hpaiv
result
show
modifi
rndvha
vector
avirul
chick
icpi
valu
thu
vector
select
agent
would
pose
threat
poultri
industri
studi
two
modifi
rndv
vector
one
contain
la
hn
contain
ako
f
show
enhanc
express
hpaiv
ha
protein
incorpor
ha
protein
ndv
particl
thu
two
modifi
rndvha
vector
chosen
evalu
immunogen
protect
efficaci
hpaiv
parallel
lasotaha
vector
immun
studi
show
serum
sampl
immun
chicken
three
rndv
wpi
high
level
hi
titer
ndv
hpaiv
suggest
vector
effici
earli
wpi
wpi
titer
serum
sampl
immun
chicken
remain
high
subsequ
challeng
hpaiv
show
vector
induc
substanti
protect
hpaiv
challeng
specif
wherea
unimmun
chicken
die
dpc
immun
chicken
remain
free
diseas
without
replic
detect
infecti
challeng
viru
tissu
sampl
howev
evalu
tracheal
cloacal
swab
taken
dpc
reveal
differ
level
protect
specif
rndvako
f
vector
complet
prevent
detect
hpaiv
shed
bird
rndvla
hnha
vector
next
protect
shed
detect
swab
rlasotaha
least
protect
shed
detect
swab
result
suggest
two
modifi
rndv
vector
effici
restrict
replic
hpaiv
challeng
viru
current
rlasota
vector
sinc
viru
shed
transmit
hpaiv
unvaccin
flock
human
ideal
hpaiv
vaccin
complet
prevent
challeng
viru
replic
shed
suggest
rndvako
f
vector
repres
improv
hpaiv
vaccin
poultri
summari
find
show
mesogen
ndv
strain
bc
modifi
possibl
use
avirul
safe
effect
vaccin
vector
chicken
rndv
vector
replic
higher
level
vitro
chicken
rlasota
viru
without
caus
clinic
sign
studi
identifi
two
improv
rndv
vector
induc
higher
level
immunogen
protect
efficaci
hpaiv
whether
two
rndv
vector
would
also
provid
increas
immunogen
protect
hpaiv
mammalian
speci
remain
identifi
induct
serum
antibodi
chicken
respons
infect
rndv
vector
vaccin
chicken
inocul
viru
eid
intranas
rout
serum
sampl
collect
wpi
virusspecif
antibodi
determin
hemagglutin
inhibit
assay
use
hpaiv
ndv
strain
gb
texa
b
kim
tabl
oral
cloacal
shed
hpaiv
challeng
viru
chicken
immun
week
earlier
rndv
express
hpaiv
ha
protein
identifi
shed
challeng
viru
aliquot
collect
sampl
inocul
three
egg
per
sampl
allanto
fluid
collect
dpi
viru
replic
determin
hemagglutin
assay
detect
viru
three
egg
consid
posit
day
swab
shown
shed
detect
day
swab
note
studi
includ
mockimmun
group
challeng
n
bird
die
day
postchalleng
sampl
